Health CanadaGeneral Alert
New restrictions on the use of rosiglitazone products due to cardiac safety conc...
Published: November 6, 2007Recall ID: 24241Category: generalCountry: Canada
Product Description & Identification
New restrictions on the use of rosiglitazone products due to cardiac safety concerns (Avandia, Avandamet, Avandaryl) - For Health Professionals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24241 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/new-restrictions-use-rosiglitazone-products-due-cardiac-safety-concerns-avandia |
| Title | New restrictions on the use of rosiglitazone products due to cardiac safety concerns (Avandia, Avandamet, Avandaryl) - For Health Professionals |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2007-11-06 |
| Organization | Marketed health products |